nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Carglumic Acid—CPS1—obesity	0.0192	0.902	CrCbGaD
Vigabatrin—SLC36A1—hindbrain—obesity	0.0149	0.119	CbGeAlD
Vigabatrin—ABAT—hindbrain—obesity	0.0148	0.118	CbGeAlD
Vigabatrin—GABBR1—adrenal cortex—obesity	0.0097	0.0778	CbGeAlD
Vigabatrin—ABAT—islet of Langerhans—obesity	0.00956	0.0766	CbGeAlD
Vigabatrin—GABBR1—pituitary gland—obesity	0.00784	0.0628	CbGeAlD
Vigabatrin—GABBR1—adipose tissue—obesity	0.00781	0.0626	CbGeAlD
Vigabatrin—GABBR1—adrenal gland—obesity	0.007	0.0561	CbGeAlD
Vigabatrin—SLC36A1—adipose tissue—obesity	0.00613	0.0492	CbGeAlD
Vigabatrin—ABAT—pituitary gland—obesity	0.00612	0.0491	CbGeAlD
Vigabatrin—ABAT—adipose tissue—obesity	0.0061	0.0489	CbGeAlD
Vigabatrin—SLC36A1—digestive system—obesity	0.00577	0.0463	CbGeAlD
Vigabatrin—SLC36A1—adrenal gland—obesity	0.0055	0.0441	CbGeAlD
Vigabatrin—ABAT—adrenal gland—obesity	0.00547	0.0438	CbGeAlD
Vigabatrin—SLC36A1—endocrine gland—obesity	0.00477	0.0382	CbGeAlD
Vigabatrin—ABAT—endocrine gland—obesity	0.00474	0.038	CbGeAlD
Vigabatrin—SLC36A1—liver—obesity	0.0043	0.0345	CbGeAlD
Vigabatrin—ABAT—liver—obesity	0.00428	0.0343	CbGeAlD
Vigabatrin—L-Glutamine—GLUL—obesity	0.00207	0.0976	CrCbGaD
Vigabatrin—Dermatitis—Diethylpropion—obesity	0.000567	0.000964	CcSEcCtD
Vigabatrin—Dizziness—Cimetidine—obesity	0.000567	0.000963	CcSEcCtD
Vigabatrin—Headache—Diethylpropion—obesity	0.000564	0.000959	CcSEcCtD
Vigabatrin—Malnutrition—Sibutramine—obesity	0.000561	0.000954	CcSEcCtD
Vigabatrin—Back pain—Orlistat—obesity	0.000561	0.000953	CcSEcCtD
Vigabatrin—Hypoaesthesia—Bupropion—obesity	0.000559	0.00095	CcSEcCtD
Vigabatrin—Hallucination—Bupropion—obesity	0.000559	0.00095	CcSEcCtD
Vigabatrin—Muscle spasms—Orlistat—obesity	0.000557	0.000947	CcSEcCtD
Vigabatrin—Oedema peripheral—Bupropion—obesity	0.000553	0.000941	CcSEcCtD
Vigabatrin—Connective tissue disorder—Bupropion—obesity	0.000552	0.000939	CcSEcCtD
Vigabatrin—Increased appetite—Topiramate—obesity	0.000551	0.000936	CcSEcCtD
Vigabatrin—Amnesia—Topiramate—obesity	0.000551	0.000936	CcSEcCtD
Vigabatrin—Tension—Sibutramine—obesity	0.00055	0.000936	CcSEcCtD
Vigabatrin—Vision blurred—Orlistat—obesity	0.000546	0.000929	CcSEcCtD
Vigabatrin—Nervousness—Sibutramine—obesity	0.000545	0.000926	CcSEcCtD
Vigabatrin—Vomiting—Cimetidine—obesity	0.000545	0.000926	CcSEcCtD
Vigabatrin—Thirst—Topiramate—obesity	0.000544	0.000924	CcSEcCtD
Vigabatrin—Back pain—Sibutramine—obesity	0.000543	0.000923	CcSEcCtD
Vigabatrin—Visual impairment—Bupropion—obesity	0.000541	0.00092	CcSEcCtD
Vigabatrin—Rash—Cimetidine—obesity	0.00054	0.000919	CcSEcCtD
Vigabatrin—Dermatitis—Cimetidine—obesity	0.00054	0.000918	CcSEcCtD
Vigabatrin—Muscle spasms—Sibutramine—obesity	0.000539	0.000917	CcSEcCtD
Vigabatrin—Ill-defined disorder—Orlistat—obesity	0.000538	0.000914	CcSEcCtD
Vigabatrin—Headache—Cimetidine—obesity	0.000537	0.000913	CcSEcCtD
Vigabatrin—Purpura—Topiramate—obesity	0.000537	0.000913	CcSEcCtD
Vigabatrin—Nausea—Diethylpropion—obesity	0.000535	0.000909	CcSEcCtD
Vigabatrin—Erythema multiforme—Bupropion—obesity	0.000531	0.000903	CcSEcCtD
Vigabatrin—Angioedema—Orlistat—obesity	0.00053	0.0009	CcSEcCtD
Vigabatrin—Vision blurred—Sibutramine—obesity	0.000529	0.000899	CcSEcCtD
Vigabatrin—Lethargy—Topiramate—obesity	0.000528	0.000898	CcSEcCtD
Vigabatrin—Tremor—Sibutramine—obesity	0.000526	0.000894	CcSEcCtD
Vigabatrin—Eye disorder—Bupropion—obesity	0.000525	0.000893	CcSEcCtD
Vigabatrin—Tinnitus—Bupropion—obesity	0.000524	0.000891	CcSEcCtD
Vigabatrin—Malaise—Orlistat—obesity	0.000523	0.000889	CcSEcCtD
Vigabatrin—Vertigo—Orlistat—obesity	0.000521	0.000885	CcSEcCtD
Vigabatrin—Ill-defined disorder—Sibutramine—obesity	0.00052	0.000885	CcSEcCtD
Vigabatrin—Anaemia—Sibutramine—obesity	0.000518	0.000881	CcSEcCtD
Vigabatrin—Pain in extremity—Topiramate—obesity	0.000517	0.00088	CcSEcCtD
Vigabatrin—Osteoarthritis—Topiramate—obesity	0.000517	0.00088	CcSEcCtD
Vigabatrin—Diplopia—Topiramate—obesity	0.000517	0.00088	CcSEcCtD
Vigabatrin—Agitation—Sibutramine—obesity	0.000515	0.000876	CcSEcCtD
Vigabatrin—Angioedema—Sibutramine—obesity	0.000513	0.000871	CcSEcCtD
Vigabatrin—Affect lability—Topiramate—obesity	0.000509	0.000866	CcSEcCtD
Vigabatrin—Nausea—Cimetidine—obesity	0.000509	0.000865	CcSEcCtD
Vigabatrin—Malaise—Sibutramine—obesity	0.000506	0.00086	CcSEcCtD
Vigabatrin—Cough—Orlistat—obesity	0.000506	0.00086	CcSEcCtD
Vigabatrin—Psychotic disorder—Topiramate—obesity	0.000505	0.000859	CcSEcCtD
Vigabatrin—Vertigo—Sibutramine—obesity	0.000504	0.000857	CcSEcCtD
Vigabatrin—Convulsion—Orlistat—obesity	0.000502	0.000854	CcSEcCtD
Vigabatrin—Face oedema—Topiramate—obesity	0.000499	0.000849	CcSEcCtD
Vigabatrin—Irritability—Topiramate—obesity	0.000494	0.00084	CcSEcCtD
Vigabatrin—Myalgia—Orlistat—obesity	0.000493	0.000839	CcSEcCtD
Vigabatrin—Chest pain—Orlistat—obesity	0.000493	0.000839	CcSEcCtD
Vigabatrin—Mental disorder—Bupropion—obesity	0.000492	0.000837	CcSEcCtD
Vigabatrin—Anxiety—Orlistat—obesity	0.000492	0.000836	CcSEcCtD
Vigabatrin—Mood swings—Topiramate—obesity	0.00049	0.000833	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00049	0.000833	CcSEcCtD
Vigabatrin—Cough—Sibutramine—obesity	0.000489	0.000832	CcSEcCtD
Vigabatrin—Malnutrition—Bupropion—obesity	0.000489	0.000831	CcSEcCtD
Vigabatrin—Discomfort—Orlistat—obesity	0.000488	0.000829	CcSEcCtD
Vigabatrin—Ataxia—Topiramate—obesity	0.000486	0.000827	CcSEcCtD
Vigabatrin—Convulsion—Sibutramine—obesity	0.000486	0.000826	CcSEcCtD
Vigabatrin—Tension—Bupropion—obesity	0.00048	0.000816	CcSEcCtD
Vigabatrin—Arthralgia—Sibutramine—obesity	0.000478	0.000812	CcSEcCtD
Vigabatrin—Chest pain—Sibutramine—obesity	0.000478	0.000812	CcSEcCtD
Vigabatrin—Myalgia—Sibutramine—obesity	0.000478	0.000812	CcSEcCtD
Vigabatrin—Anxiety—Sibutramine—obesity	0.000476	0.000809	CcSEcCtD
Vigabatrin—Nervousness—Bupropion—obesity	0.000475	0.000808	CcSEcCtD
Vigabatrin—Oedema—Orlistat—obesity	0.000473	0.000804	CcSEcCtD
Vigabatrin—Back pain—Bupropion—obesity	0.000473	0.000804	CcSEcCtD
Vigabatrin—Abdominal pain upper—Topiramate—obesity	0.000472	0.000803	CcSEcCtD
Vigabatrin—Discomfort—Sibutramine—obesity	0.000472	0.000802	CcSEcCtD
Vigabatrin—Muscle spasms—Bupropion—obesity	0.00047	0.000799	CcSEcCtD
Vigabatrin—Infection—Orlistat—obesity	0.00047	0.000799	CcSEcCtD
Vigabatrin—Breast disorder—Topiramate—obesity	0.000467	0.000795	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Topiramate—obesity	0.000466	0.000792	CcSEcCtD
Vigabatrin—Nervous system disorder—Orlistat—obesity	0.000464	0.000789	CcSEcCtD
Vigabatrin—Nasopharyngitis—Topiramate—obesity	0.000463	0.000787	CcSEcCtD
Vigabatrin—Confusional state—Sibutramine—obesity	0.000462	0.000785	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—C3—obesity	0.000461	0.00173	CbGpPWpGaD
Vigabatrin—Vision blurred—Bupropion—obesity	0.000461	0.000784	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—PRKCB—obesity	0.00046	0.00173	CbGpPWpGaD
Vigabatrin—Skin disorder—Orlistat—obesity	0.000459	0.000781	CcSEcCtD
Vigabatrin—Tremor—Bupropion—obesity	0.000458	0.000779	CcSEcCtD
Vigabatrin—Oedema—Sibutramine—obesity	0.000458	0.000778	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—NPY2R—obesity	0.000457	0.00172	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—NPY1R—obesity	0.000457	0.00172	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—MC4R—obesity	0.000457	0.00172	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—MC3R—obesity	0.000457	0.00172	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PRKAR2B—obesity	0.000457	0.00172	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—HTR2C—obesity	0.000456	0.00171	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—DRD1—obesity	0.000456	0.00171	CbGpPWpGaD
Vigabatrin—Infection—Sibutramine—obesity	0.000455	0.000773	CcSEcCtD
Vigabatrin—Ill-defined disorder—Bupropion—obesity	0.000454	0.000771	CcSEcCtD
Vigabatrin—Anaemia—Bupropion—obesity	0.000452	0.000768	CcSEcCtD
Vigabatrin—Abdominal distension—Topiramate—obesity	0.00045	0.000765	CcSEcCtD
Vigabatrin—Agitation—Bupropion—obesity	0.000449	0.000764	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PPY—obesity	0.000448	0.00169	CbGpPWpGaD
Vigabatrin—Angioedema—Bupropion—obesity	0.000447	0.00076	CcSEcCtD
Vigabatrin—Skin disorder—Sibutramine—obesity	0.000445	0.000756	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—ADRB1—obesity	0.000441	0.00166	CbGpPWpGaD
Vigabatrin—Malaise—Bupropion—obesity	0.000441	0.00075	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GIP—obesity	0.00044	0.00165	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PRKCH—obesity	0.00044	0.00165	CbGpPWpGaD
Vigabatrin—Vertigo—Bupropion—obesity	0.000439	0.000747	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—AGT—obesity	0.000438	0.00165	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HCRT—obesity	0.000433	0.00163	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PMCH—obesity	0.000433	0.00163	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NMU—obesity	0.000433	0.00163	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NPY5R—obesity	0.000433	0.00163	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GHRL—obesity	0.000432	0.00162	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Orlistat—obesity	0.000431	0.000733	CcSEcCtD
Vigabatrin—Bronchitis—Topiramate—obesity	0.00043	0.000731	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GCK—obesity	0.00043	0.00162	CbGpPWpGaD
Vigabatrin—Abdominal discomfort—Topiramate—obesity	0.000429	0.000729	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—DRD4—obesity	0.000428	0.00161	CbGpPWpGaD
Vigabatrin—Insomnia—Orlistat—obesity	0.000428	0.000727	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PRLH—obesity	0.000427	0.00161	CbGpPWpGaD
Vigabatrin—Cough—Bupropion—obesity	0.000427	0.000726	CcSEcCtD
Vigabatrin—Paraesthesia—Orlistat—obesity	0.000425	0.000722	CcSEcCtD
Vigabatrin—Convulsion—Bupropion—obesity	0.000424	0.00072	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Sibutramine—obesity	0.000417	0.000709	CcSEcCtD
Vigabatrin—Dyspepsia—Orlistat—obesity	0.000416	0.000708	CcSEcCtD
Vigabatrin—Myalgia—Bupropion—obesity	0.000416	0.000708	CcSEcCtD
Vigabatrin—Arthralgia—Bupropion—obesity	0.000416	0.000708	CcSEcCtD
Vigabatrin—Chest pain—Bupropion—obesity	0.000416	0.000708	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Topiramate—obesity	0.000416	0.000707	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—MC3R—obesity	0.000415	0.00156	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MC4R—obesity	0.000415	0.00156	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NPY1R—obesity	0.000415	0.00156	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NPY2R—obesity	0.000415	0.00156	CbGpPWpGaD
Vigabatrin—Anxiety—Bupropion—obesity	0.000415	0.000705	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—PRKCB—obesity	0.000415	0.00156	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—CETP—obesity	0.000415	0.00156	CbGpPWpGaD
Vigabatrin—Insomnia—Sibutramine—obesity	0.000414	0.000704	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000413	0.000703	CcSEcCtD
Vigabatrin—Erectile dysfunction—Topiramate—obesity	0.000412	0.0007	CcSEcCtD
Vigabatrin—Discomfort—Bupropion—obesity	0.000411	0.000699	CcSEcCtD
Vigabatrin—Decreased appetite—Orlistat—obesity	0.000411	0.000699	CcSEcCtD
Vigabatrin—Paraesthesia—Sibutramine—obesity	0.000411	0.000699	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TF—obesity	0.00041	0.00154	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CNR1—obesity	0.000409	0.00154	CbGpPWpGaD
Vigabatrin—Gastrointestinal disorder—Orlistat—obesity	0.000408	0.000694	CcSEcCtD
Vigabatrin—Fatigue—Orlistat—obesity	0.000408	0.000693	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PPY—obesity	0.000407	0.00153	CbGpPWpGaD
Vigabatrin—Somnolence—Sibutramine—obesity	0.000407	0.000692	CcSEcCtD
Vigabatrin—Weight increased—Topiramate—obesity	0.000407	0.000692	CcSEcCtD
Vigabatrin—Pain—Orlistat—obesity	0.000405	0.000688	CcSEcCtD
Vigabatrin—Dyspepsia—Sibutramine—obesity	0.000403	0.000685	CcSEcCtD
Vigabatrin—Confusional state—Bupropion—obesity	0.000402	0.000684	CcSEcCtD
Vigabatrin—Pneumonia—Topiramate—obesity	0.000401	0.000682	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PRKCH—obesity	0.000399	0.0015	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GIP—obesity	0.000399	0.0015	CbGpPWpGaD
Vigabatrin—Oedema—Bupropion—obesity	0.000399	0.000679	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—DRD2—obesity	0.000399	0.0015	CbGpPWpGaD
Vigabatrin—Infestation NOS—Topiramate—obesity	0.000399	0.000678	CcSEcCtD
Vigabatrin—Infestation—Topiramate—obesity	0.000399	0.000678	CcSEcCtD
Vigabatrin—Decreased appetite—Sibutramine—obesity	0.000398	0.000677	CcSEcCtD
Vigabatrin—Depression—Topiramate—obesity	0.000398	0.000676	CcSEcCtD
Vigabatrin—Infection—Bupropion—obesity	0.000396	0.000674	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Topiramate—obesity	0.000395	0.000672	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Sibutramine—obesity	0.000395	0.000672	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—GCG—obesity	0.000395	0.00149	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TFRC—obesity	0.000393	0.00148	CbGpPWpGaD
Vigabatrin—Constipation—Sibutramine—obesity	0.000391	0.000666	CcSEcCtD
Vigabatrin—Pain—Sibutramine—obesity	0.000391	0.000666	CcSEcCtD
Vigabatrin—Nervous system disorder—Bupropion—obesity	0.000391	0.000665	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Topiramate—obesity	0.000391	0.000664	CcSEcCtD
Vigabatrin—Feeling abnormal—Orlistat—obesity	0.00039	0.000663	CcSEcCtD
Vigabatrin—Skin disorder—Bupropion—obesity	0.000388	0.000659	CcSEcCtD
Vigabatrin—Conjunctivitis—Topiramate—obesity	0.000388	0.000659	CcSEcCtD
Vigabatrin—Urinary tract infection—Topiramate—obesity	0.000388	0.000659	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Orlistat—obesity	0.000387	0.000658	CcSEcCtD
Vigabatrin—Feeling abnormal—Sibutramine—obesity	0.000377	0.000641	CcSEcCtD
Vigabatrin—Urticaria—Orlistat—obesity	0.000376	0.000639	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Sibutramine—obesity	0.000374	0.000636	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRB3—obesity	0.000374	0.00141	CbGpPWpGaD
Vigabatrin—Sinusitis—Topiramate—obesity	0.000374	0.000636	CcSEcCtD
Vigabatrin—Abdominal pain—Orlistat—obesity	0.000374	0.000636	CcSEcCtD
Vigabatrin—Body temperature increased—Orlistat—obesity	0.000374	0.000636	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—POMC—obesity	0.000369	0.00139	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GAL—obesity	0.000365	0.00137	CbGpPWpGaD
Vigabatrin—Urticaria—Sibutramine—obesity	0.000364	0.000618	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Bupropion—obesity	0.000364	0.000618	CcSEcCtD
Vigabatrin—Abdominal pain—Sibutramine—obesity	0.000362	0.000615	CcSEcCtD
Vigabatrin—Body temperature increased—Sibutramine—obesity	0.000362	0.000615	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—C5AR1—obesity	0.000361	0.00136	CbGpPWpGaD
Vigabatrin—Insomnia—Bupropion—obesity	0.000361	0.000614	CcSEcCtD
Vigabatrin—Paraesthesia—Bupropion—obesity	0.000358	0.000609	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—ADRB2—obesity	0.000357	0.00134	CbGpPWpGaD
Vigabatrin—Hallucination—Topiramate—obesity	0.000356	0.000605	CcSEcCtD
Vigabatrin—Hypoaesthesia—Topiramate—obesity	0.000356	0.000605	CcSEcCtD
Vigabatrin—Somnolence—Bupropion—obesity	0.000355	0.000603	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—NMB—obesity	0.000354	0.00133	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GHRH—obesity	0.000354	0.00133	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—PRKCB—obesity	0.000353	0.00133	CbGpPWpGaD
Vigabatrin—Oedema peripheral—Topiramate—obesity	0.000353	0.000599	CcSEcCtD
Vigabatrin—Connective tissue disorder—Topiramate—obesity	0.000352	0.000598	CcSEcCtD
Vigabatrin—Dyspepsia—Bupropion—obesity	0.000351	0.000597	CcSEcCtD
Vigabatrin—Hypersensitivity—Orlistat—obesity	0.000349	0.000593	CcSEcCtD
Vigabatrin—Decreased appetite—Bupropion—obesity	0.000347	0.00059	CcSEcCtD
Vigabatrin—Visual impairment—Topiramate—obesity	0.000345	0.000586	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Bupropion—obesity	0.000345	0.000586	CcSEcCtD
Vigabatrin—Fatigue—Bupropion—obesity	0.000344	0.000585	CcSEcCtD
Vigabatrin—Constipation—Bupropion—obesity	0.000341	0.00058	CcSEcCtD
Vigabatrin—Pain—Bupropion—obesity	0.000341	0.00058	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—GNB3—obesity	0.00034	0.00128	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRB3—obesity	0.00034	0.00128	CbGpPWpGaD
Vigabatrin—Asthenia—Orlistat—obesity	0.000339	0.000577	CcSEcCtD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—obesity	0.000339	0.00127	CbGpPWpGaD
Vigabatrin—Erythema multiforme—Topiramate—obesity	0.000338	0.000575	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FFAR4—obesity	0.000337	0.00127	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Sibutramine—obesity	0.000337	0.000573	CcSEcCtD
Vigabatrin—Pruritus—Orlistat—obesity	0.000335	0.000569	CcSEcCtD
Vigabatrin—Eye disorder—Topiramate—obesity	0.000334	0.000569	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A4—obesity	0.000334	0.00126	CbGpPWpGaD
Vigabatrin—Tinnitus—Topiramate—obesity	0.000334	0.000567	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GAL—obesity	0.000332	0.00125	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GNAS—obesity	0.000331	0.00125	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCK—obesity	0.00033	0.00124	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—CYCS—obesity	0.00033	0.00124	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Bupropion—obesity	0.000329	0.000559	CcSEcCtD
Vigabatrin—Asthenia—Sibutramine—obesity	0.000328	0.000558	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—C5AR1—obesity	0.000328	0.00123	CbGpPWpGaD
Vigabatrin—Gastrointestinal pain—Bupropion—obesity	0.000326	0.000555	CcSEcCtD
Vigabatrin—Pruritus—Sibutramine—obesity	0.000324	0.000551	CcSEcCtD
Vigabatrin—Diarrhoea—Orlistat—obesity	0.000324	0.00055	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GHSR—obesity	0.000323	0.00122	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MCHR1—obesity	0.000323	0.00122	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BRS3—obesity	0.000323	0.00122	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GLP1R—obesity	0.000322	0.00121	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—NCOA1—obesity	0.000319	0.0012	CbGpPWpGaD
Vigabatrin—Urticaria—Bupropion—obesity	0.000317	0.000539	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCL5—obesity	0.000317	0.00119	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HRH3—obesity	0.000317	0.00119	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCKAR—obesity	0.000317	0.00119	CbGpPWpGaD
Vigabatrin—Body temperature increased—Bupropion—obesity	0.000315	0.000536	CcSEcCtD
Vigabatrin—Abdominal pain—Bupropion—obesity	0.000315	0.000536	CcSEcCtD
Vigabatrin—Mental disorder—Topiramate—obesity	0.000314	0.000533	CcSEcCtD
Vigabatrin—Diarrhoea—Sibutramine—obesity	0.000313	0.000533	CcSEcCtD
Vigabatrin—Dizziness—Orlistat—obesity	0.000313	0.000532	CcSEcCtD
Vigabatrin—Malnutrition—Topiramate—obesity	0.000312	0.00053	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PLG—obesity	0.000311	0.00117	CbGpPWpGaD
Vigabatrin—Tension—Topiramate—obesity	0.000306	0.00052	CcSEcCtD
Vigabatrin—Dizziness—Sibutramine—obesity	0.000303	0.000515	CcSEcCtD
Vigabatrin—Nervousness—Topiramate—obesity	0.000303	0.000514	CcSEcCtD
Vigabatrin—Back pain—Topiramate—obesity	0.000301	0.000512	CcSEcCtD
Vigabatrin—Vomiting—Orlistat—obesity	0.000301	0.000511	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PRLHR—obesity	0.000301	0.00113	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GH1—obesity	0.000301	0.00113	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SH2B1—obesity	0.000301	0.00113	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCK—obesity	0.0003	0.00113	CbGpPWpGaD
Vigabatrin—Muscle spasms—Topiramate—obesity	0.0003	0.000509	CcSEcCtD
Vigabatrin—Rash—Orlistat—obesity	0.000298	0.000507	CcSEcCtD
Vigabatrin—Dermatitis—Orlistat—obesity	0.000298	0.000507	CcSEcCtD
Vigabatrin—Headache—Orlistat—obesity	0.000296	0.000504	CcSEcCtD
Vigabatrin—Hypersensitivity—Bupropion—obesity	0.000294	0.0005	CcSEcCtD
Vigabatrin—Vision blurred—Topiramate—obesity	0.000294	0.000499	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GLP1R—obesity	0.000292	0.0011	CbGpPWpGaD
Vigabatrin—Tremor—Topiramate—obesity	0.000292	0.000496	CcSEcCtD
Vigabatrin—Vomiting—Sibutramine—obesity	0.000291	0.000495	CcSEcCtD
Vigabatrin—Ill-defined disorder—Topiramate—obesity	0.000289	0.000491	CcSEcCtD
Vigabatrin—Rash—Sibutramine—obesity	0.000289	0.000491	CcSEcCtD
Vigabatrin—Dermatitis—Sibutramine—obesity	0.000288	0.00049	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GNB3—obesity	0.000288	0.00108	CbGpPWpGaD
Vigabatrin—Anaemia—Topiramate—obesity	0.000288	0.00049	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—HRH3—obesity	0.000288	0.00108	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCKAR—obesity	0.000288	0.00108	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—NPY—obesity	0.000287	0.00108	CbGpPWpGaD
Vigabatrin—Headache—Sibutramine—obesity	0.000287	0.000488	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—HMOX1—obesity	0.000287	0.00108	CbGpPWpGaD
Vigabatrin—Asthenia—Bupropion—obesity	0.000286	0.000487	CcSEcCtD
Vigabatrin—Agitation—Topiramate—obesity	0.000286	0.000487	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—IAPP—obesity	0.000285	0.00107	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APLN—obesity	0.000283	0.00106	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PYY—obesity	0.000283	0.00106	CbGpPWpGaD
Vigabatrin—Pruritus—Bupropion—obesity	0.000282	0.00048	CcSEcCtD
Vigabatrin—Nausea—Orlistat—obesity	0.000281	0.000478	CcSEcCtD
Vigabatrin—Malaise—Topiramate—obesity	0.000281	0.000478	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GNAS—obesity	0.000281	0.00106	CbGpPWpGaD
Vigabatrin—Vertigo—Topiramate—obesity	0.00028	0.000476	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—HTR2A—obesity	0.000279	0.00105	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—C3—obesity	0.000279	0.00105	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PRKAR2B—obesity	0.000277	0.00104	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CRH—obesity	0.000277	0.00104	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HTR1B—obesity	0.000277	0.00104	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—APOB—obesity	0.000275	0.00103	CbGpPWpGaD
Vigabatrin—Diarrhoea—Bupropion—obesity	0.000273	0.000464	CcSEcCtD
Vigabatrin—Nausea—Sibutramine—obesity	0.000272	0.000462	CcSEcCtD
Vigabatrin—Cough—Topiramate—obesity	0.000272	0.000462	CcSEcCtD
Vigabatrin—Convulsion—Topiramate—obesity	0.00027	0.000459	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PNLIP—obesity	0.000268	0.00101	CbGpPWpGaD
Vigabatrin—Arthralgia—Topiramate—obesity	0.000265	0.000451	CcSEcCtD
Vigabatrin—Myalgia—Topiramate—obesity	0.000265	0.000451	CcSEcCtD
Vigabatrin—Chest pain—Topiramate—obesity	0.000265	0.000451	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—AGT—obesity	0.000265	0.000997	CbGpPWpGaD
Vigabatrin—Anxiety—Topiramate—obesity	0.000264	0.000449	CcSEcCtD
Vigabatrin—Dizziness—Bupropion—obesity	0.000264	0.000449	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000263	0.000448	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—NPS—obesity	0.000262	0.000987	CbGpPWpGaD
Vigabatrin—Discomfort—Topiramate—obesity	0.000262	0.000446	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SDC3—obesity	0.000262	0.000984	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NPY—obesity	0.000261	0.00098	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IAPP—obesity	0.000259	0.000974	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HTR2C—obesity	0.000257	0.000968	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—DRD1—obesity	0.000257	0.000968	CbGpPWpGaD
Vigabatrin—Confusional state—Topiramate—obesity	0.000256	0.000436	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—NPY5R—obesity	0.000256	0.000962	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PMCH—obesity	0.000256	0.000962	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HCRT—obesity	0.000256	0.000962	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NMU—obesity	0.000256	0.000962	CbGpPWpGaD
Vigabatrin—Oedema—Topiramate—obesity	0.000254	0.000432	CcSEcCtD
Vigabatrin—Vomiting—Bupropion—obesity	0.000254	0.000431	CcSEcCtD
Vigabatrin—Infection—Topiramate—obesity	0.000253	0.000429	CcSEcCtD
Vigabatrin—Rash—Bupropion—obesity	0.000252	0.000428	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—HTR1B—obesity	0.000251	0.000946	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CRH—obesity	0.000251	0.000946	CbGpPWpGaD
Vigabatrin—Dermatitis—Bupropion—obesity	0.000251	0.000427	CcSEcCtD
Vigabatrin—Headache—Bupropion—obesity	0.00025	0.000425	CcSEcCtD
Vigabatrin—Nervous system disorder—Topiramate—obesity	0.000249	0.000424	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRB1—obesity	0.000249	0.000938	CbGpPWpGaD
Vigabatrin—Skin disorder—Topiramate—obesity	0.000247	0.00042	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—NPY2R—obesity	0.000245	0.000922	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MC3R—obesity	0.000245	0.000922	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NPY1R—obesity	0.000245	0.000922	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MC4R—obesity	0.000245	0.000922	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—F2—obesity	0.000245	0.000921	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GHRL—obesity	0.000244	0.000918	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—DRD4—obesity	0.000242	0.00091	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PPY—obesity	0.00024	0.000904	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NPS—obesity	0.000238	0.000897	CbGpPWpGaD
Vigabatrin—Nausea—Bupropion—obesity	0.000237	0.000403	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PRKCH—obesity	0.000236	0.000888	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HDAC8—obesity	0.000236	0.000888	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GIP—obesity	0.000236	0.000888	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—DRD1—obesity	0.000234	0.000879	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HTR2C—obesity	0.000234	0.000879	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PPARA—obesity	0.000232	0.000871	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Topiramate—obesity	0.000232	0.000394	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CNR1—obesity	0.000231	0.000869	CbGpPWpGaD
Vigabatrin—Insomnia—Topiramate—obesity	0.00023	0.000391	CcSEcCtD
Vigabatrin—Paraesthesia—Topiramate—obesity	0.000228	0.000388	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—ADRB1—obesity	0.000226	0.000852	CbGpPWpGaD
Vigabatrin—Somnolence—Topiramate—obesity	0.000226	0.000384	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—DRD2—obesity	0.000225	0.000848	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LEPR—obesity	0.000224	0.000843	CbGpPWpGaD
Vigabatrin—Dyspepsia—Topiramate—obesity	0.000224	0.000381	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GCG—obesity	0.000223	0.00084	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—POMC—obesity	0.000223	0.000839	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GHRL—obesity	0.000222	0.000834	CbGpPWpGaD
Vigabatrin—Decreased appetite—Topiramate—obesity	0.000221	0.000376	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—DRD4—obesity	0.00022	0.000827	CbGpPWpGaD
Vigabatrin—Gastrointestinal disorder—Topiramate—obesity	0.00022	0.000373	CcSEcCtD
Vigabatrin—Fatigue—Topiramate—obesity	0.000219	0.000373	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCL2—obesity	0.000218	0.000821	CbGpPWpGaD
Vigabatrin—Constipation—Topiramate—obesity	0.000217	0.00037	CcSEcCtD
Vigabatrin—Pain—Topiramate—obesity	0.000217	0.00037	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—APOA1—obesity	0.000217	0.000817	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CNR1—obesity	0.00021	0.000789	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Topiramate—obesity	0.00021	0.000356	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Topiramate—obesity	0.000208	0.000354	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—DRD2—obesity	0.000205	0.00077	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GCG—obesity	0.000203	0.000762	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRB2—obesity	0.000202	0.00076	CbGpPWpGaD
Vigabatrin—Urticaria—Topiramate—obesity	0.000202	0.000343	CcSEcCtD
Vigabatrin—Abdominal pain—Topiramate—obesity	0.000201	0.000342	CcSEcCtD
Vigabatrin—Body temperature increased—Topiramate—obesity	0.000201	0.000342	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ADRB3—obesity	0.000201	0.000755	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GAL—obesity	0.000196	0.000737	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—C5AR1—obesity	0.000194	0.000729	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GNB3—obesity	0.000192	0.000724	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Topiramate—obesity	0.000187	0.000319	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GNAS—obesity	0.000187	0.000705	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRB2—obesity	0.000183	0.00069	CbGpPWpGaD
Vigabatrin—Asthenia—Topiramate—obesity	0.000182	0.00031	CcSEcCtD
Vigabatrin—Pruritus—Topiramate—obesity	0.00018	0.000306	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CCL5—obesity	0.000179	0.000674	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCK—obesity	0.000177	0.000667	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKG1—obesity	0.000177	0.000667	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GNB3—obesity	0.000175	0.000657	CbGpPWpGaD
Vigabatrin—Diarrhoea—Topiramate—obesity	0.000174	0.000296	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GLP1R—obesity	0.000173	0.00065	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RBP4—obesity	0.000173	0.00065	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—obesity	0.000172	0.000648	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GNAS—obesity	0.00017	0.00064	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HRH3—obesity	0.00017	0.000639	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCKAR—obesity	0.00017	0.000639	CbGpPWpGaD
Vigabatrin—Dizziness—Topiramate—obesity	0.000168	0.000286	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PRKAR2B—obesity	0.000164	0.000615	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL5—obesity	0.000163	0.000612	CbGpPWpGaD
Vigabatrin—Vomiting—Topiramate—obesity	0.000162	0.000275	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PRKCD—obesity	0.000161	0.000607	CbGpPWpGaD
Vigabatrin—Rash—Topiramate—obesity	0.00016	0.000273	CcSEcCtD
Vigabatrin—Dermatitis—Topiramate—obesity	0.00016	0.000272	CcSEcCtD
Vigabatrin—Headache—Topiramate—obesity	0.000159	0.000271	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—NCF2—obesity	0.000158	0.000594	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HTR2A—obesity	0.000158	0.000594	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—C3—obesity	0.000158	0.000593	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NPY—obesity	0.000154	0.000579	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOC3—obesity	0.000153	0.000576	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IAPP—obesity	0.000153	0.000576	CbGpPWpGaD
Vigabatrin—Nausea—Topiramate—obesity	0.000151	0.000257	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AGT—obesity	0.00015	0.000564	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HTR1B—obesity	0.000149	0.000559	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CRH—obesity	0.000149	0.000559	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SDC1—obesity	0.000147	0.000552	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PRKCD—obesity	0.000147	0.000551	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKR1C3—obesity	0.000144	0.000543	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HTR2A—obesity	0.000143	0.000539	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—C3—obesity	0.000143	0.000539	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NPS—obesity	0.000141	0.00053	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—F2—obesity	0.000138	0.000521	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PRKCB—obesity	0.000138	0.000521	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HTR2C—obesity	0.000138	0.000519	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—DRD1—obesity	0.000138	0.000519	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AGT—obesity	0.000136	0.000512	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NTRK2—obesity	0.000134	0.000505	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRB1—obesity	0.000134	0.000503	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CG—obesity	0.000132	0.000498	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PARP1—obesity	0.000131	0.000492	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GHRL—obesity	0.000131	0.000492	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—DRD4—obesity	0.00013	0.000488	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—POMC—obesity	0.000126	0.000474	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PRKCB—obesity	0.000126	0.000473	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—F2—obesity	0.000126	0.000473	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CNR1—obesity	0.000124	0.000466	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TCF7L2—obesity	0.000122	0.000458	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT2—obesity	0.000121	0.000456	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—DRD2—obesity	0.000121	0.000455	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CG—obesity	0.00012	0.000453	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GCG—obesity	0.00012	0.00045	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTPN1—obesity	0.00012	0.00045	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CD—obesity	0.000116	0.000438	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—POMC—obesity	0.000115	0.000431	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRL—obesity	0.000114	0.00043	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STK11—obesity	0.000113	0.000423	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL2—obesity	0.000112	0.000421	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PLG—obesity	0.000111	0.000419	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RHOA—obesity	0.000111	0.000418	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT2—obesity	0.00011	0.000414	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3R1—obesity	0.00011	0.000414	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FOXO3—obesity	0.000109	0.000409	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRB2—obesity	0.000108	0.000408	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SOCS1—obesity	0.000107	0.000401	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CD—obesity	0.000106	0.000398	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SOCS3—obesity	0.000105	0.000396	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GNB3—obesity	0.000103	0.000388	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—TYK2—obesity	0.000102	0.000383	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CB—obesity	0.000102	0.000382	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF2—obesity	0.000101	0.000381	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—RHOA—obesity	0.000101	0.00038	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GNAS—obesity	0.0001	0.000378	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3R1—obesity	9.99e-05	0.000376	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOB—obesity	9.84e-05	0.00037	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL5—obesity	9.61e-05	0.000361	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LPL—obesity	9.4e-05	0.000353	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FOXO1—obesity	9.33e-05	0.000351	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RPS6KB1—obesity	9.31e-05	0.00035	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CB—obesity	9.22e-05	0.000347	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKCD—obesity	8.66e-05	0.000326	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HTR2A—obesity	8.47e-05	0.000319	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—C3—obesity	8.46e-05	0.000318	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IRS2—obesity	8.05e-05	0.000303	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGT—obesity	8.04e-05	0.000302	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LEP—obesity	7.88e-05	0.000296	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOE—obesity	7.88e-05	0.000296	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CAV1—obesity	7.8e-05	0.000293	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOA1—obesity	7.78e-05	0.000293	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ESR1—obesity	7.52e-05	0.000283	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKCB—obesity	7.43e-05	0.000279	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—F2—obesity	7.43e-05	0.000279	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BAD—obesity	7.34e-05	0.000276	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CG—obesity	7.11e-05	0.000267	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IRS1—obesity	7.03e-05	0.000264	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—POMC—obesity	6.77e-05	0.000254	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—INS—obesity	6.73e-05	0.000253	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL2—obesity	6.62e-05	0.000249	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1—obesity	6.51e-05	0.000245	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT2—obesity	6.5e-05	0.000245	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CD—obesity	6.25e-05	0.000235	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CA—obesity	6.19e-05	0.000233	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SERPINE1—obesity	6.18e-05	0.000232	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TYK2—obesity	6.01e-05	0.000226	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RHOA—obesity	5.96e-05	0.000224	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3R1—obesity	5.9e-05	0.000222	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOS3—obesity	5.9e-05	0.000222	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CA—obesity	5.62e-05	0.000211	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MTOR—obesity	5.45e-05	0.000205	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CB—obesity	5.45e-05	0.000205	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT1—obesity	5.06e-05	0.00019	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—obesity	4.98e-05	0.000187	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—obesity	4.73e-05	0.000178	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK8—obesity	4.6e-05	0.000173	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT1—obesity	4.59e-05	0.000173	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STAT3—obesity	4.21e-05	0.000158	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MYC—obesity	3.91e-05	0.000147	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TGFB1—obesity	3.9e-05	0.000147	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CA—obesity	3.32e-05	0.000125	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—obesity	2.94e-05	0.000111	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT1—obesity	2.71e-05	0.000102	CbGpPWpGaD
